Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
ClouDr Group Limited ( (HK:9955) ) has provided an announcement.
ClouDr Group Limited reported a decline in revenue and an increase in losses for the year ended December 31, 2024. The company’s revenue decreased by 5.5% to RMB 3,488,094,000, while the loss for the year increased by 50.1% to RMB 491,390,000. The company experienced a significant drop in its Subscription Solution revenue, while its P2M Solution saw substantial growth. The Board decided not to distribute a final dividend for the year, reflecting the challenging financial performance.
More about ClouDr Group Limited
ClouDr Group Limited operates in the healthcare technology industry, providing a range of solutions including in-hospital, out-of-hospital, and proprietary product sales through strategic partnerships with pharmaceutical companies.
YTD Price Performance: 1.67%
Average Trading Volume: 4,015,991
Technical Sentiment Signal: Buy
Current Market Cap: HK$725.5M
See more insights into 9955 stock on TipRanks’ Stock Analysis page.